- Home
- PRSO vs SHPH Comparison
PRSO vs SHPH Comparison
Compare PRSO & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- SHPH
- Stock Information
- Founded
- PRSO 2008
- SHPH 2012
- Country
- PRSO United States
- SHPH United States
- Employees
- PRSO N/A
- SHPH N/A
- Industry
- PRSO Semiconductors
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- SHPH Health Care
- Exchange
- PRSO Nasdaq
- SHPH Nasdaq
- Market Cap
- PRSO 3.3M
- SHPH 3.2M
- IPO Year
- PRSO 2001
- SHPH 2022
- Fundamental
- Price
- PRSO $0.94
- SHPH $0.62
- Analyst Decision
- PRSO Strong Buy
- SHPH
- Analyst Count
- PRSO 2
- SHPH 0
- Target Price
- PRSO $3.38
- SHPH N/A
- AVG Volume (30 Days)
- PRSO 76.9K
- SHPH 47.0K
- Earning Date
- PRSO 03-17-2025
- SHPH 03-20-2025
- Dividend Yield
- PRSO N/A
- SHPH N/A
- EPS Growth
- PRSO N/A
- SHPH N/A
- EPS
- PRSO N/A
- SHPH N/A
- Revenue
- PRSO $12,728,000.00
- SHPH N/A
- Revenue This Year
- PRSO $9.59
- SHPH N/A
- Revenue Next Year
- PRSO $1.63
- SHPH N/A
- P/E Ratio
- PRSO N/A
- SHPH N/A
- Revenue Growth
- PRSO N/A
- SHPH N/A
- 52 Week Low
- PRSO $0.73
- SHPH $0.58
- 52 Week High
- PRSO $2.34
- SHPH $4.71
- Technical
- Relative Strength Index (RSI)
- PRSO 50.19
- SHPH 36.32
- Support Level
- PRSO $0.82
- SHPH $0.66
- Resistance Level
- PRSO $0.92
- SHPH $0.79
- Average True Range (ATR)
- PRSO 0.07
- SHPH 0.06
- MACD
- PRSO 0.02
- SHPH -0.01
- Stochastic Oscillator
- PRSO 60.38
- SHPH 11.28
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.